Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis

Introduction: Although pharmacotherapy is the most common treatment for epilepsy, proper seizure control is not achieved with current medications. This study evaluated the protective effects of the Hepatocyte Growth Factor (HGF) in a rat model of Temporal Lobe Epilepsy (TLE) and explored possible mo...

Full description

Bibliographic Details
Main Authors: Sobhan Haghani, Nida Jamali-Raeufy, Motahareh Zeinivand, Soraya Mehrabi, Leila Aryan, Javad Fahanik-Babaei
Format: Article
Language:English
Published: Iran University of Medical Sciences 2021-11-01
Series:Basic and Clinical Neuroscience
Subjects:
Online Access:http://bcn.iums.ac.ir/article-1-1562-en.html
_version_ 1827332812715327488
author Sobhan Haghani
Nida Jamali-Raeufy
Motahareh Zeinivand
Soraya Mehrabi
Leila Aryan
Javad Fahanik-Babaei
author_facet Sobhan Haghani
Nida Jamali-Raeufy
Motahareh Zeinivand
Soraya Mehrabi
Leila Aryan
Javad Fahanik-Babaei
author_sort Sobhan Haghani
collection DOAJ
description Introduction: Although pharmacotherapy is the most common treatment for epilepsy, proper seizure control is not achieved with current medications. This study evaluated the protective effects of the Hepatocyte Growth Factor (HGF) in a rat model of Temporal Lobe Epilepsy (TLE) and explored possible molecular mechanisms. Methods: A TLE rat model was determined using an intra-hippocampal kainic acid injection (4 μg). Intra-cerebrovascular injection of HGF (6 μg) was performed 30 min before kainic acid injection. Learning and memory impairment were investigated by behavioral tests. The Enzyme-Linked Immunosorbent (ELISA) was used to determine astrogliosis and DNA fragmentation. Changes in neuronal density and mossy fiber sprouting were evaluated by Nissl and Timm staining, respectively.  Results: Behavioral assessments indicated that kainate-treated rats presented spontaneous seizures. Moreover, their alternation percentage scores in the Y-Maze test were lower (P<0.001). Likewise, the passive avoidance test confirmed learning disability in Kainate-treated rats (P<0.001). HGF administration reduced the number of spontaneous seizures, alternation percentage score (P<0.001), and cognitive disturbances (P<0.001). The histopathological results also showed that a protected HGF administration contributed to the reduction of neuronal loss in the CA3 subregion of the hippocampus and inhibited the formation of aberrant Mossy Fiber Sprouting (MFS) (P<0.01). Furthermore, the ELISA data indicated a significant decrease in GFAP (P<0.01) and DNA fragmentation (P<0.05) following HGF administration. Conclusion: Our findings demonstrated the validity of HGF in protection against the progression of the kainate-induced TLE in rats. This measure improved learning, cognitive disturbances and inhibited apoptosis and astrogliosis.
first_indexed 2024-03-07T17:08:23Z
format Article
id doaj.art-f7acc44520a24f938b40e97baaee91d9
institution Directory Open Access Journal
issn 2008-126X
2228-7442
language English
last_indexed 2024-03-07T17:08:23Z
publishDate 2021-11-01
publisher Iran University of Medical Sciences
record_format Article
series Basic and Clinical Neuroscience
spelling doaj.art-f7acc44520a24f938b40e97baaee91d92024-03-03T02:25:50ZengIran University of Medical SciencesBasic and Clinical Neuroscience2008-126X2228-74422021-11-01126805816Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and AstrogliosisSobhan Haghani0Nida Jamali-Raeufy1Motahareh Zeinivand2Soraya Mehrabi3Leila Aryan4Javad Fahanik-Babaei5 Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Department of Physiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Introduction: Although pharmacotherapy is the most common treatment for epilepsy, proper seizure control is not achieved with current medications. This study evaluated the protective effects of the Hepatocyte Growth Factor (HGF) in a rat model of Temporal Lobe Epilepsy (TLE) and explored possible molecular mechanisms. Methods: A TLE rat model was determined using an intra-hippocampal kainic acid injection (4 μg). Intra-cerebrovascular injection of HGF (6 μg) was performed 30 min before kainic acid injection. Learning and memory impairment were investigated by behavioral tests. The Enzyme-Linked Immunosorbent (ELISA) was used to determine astrogliosis and DNA fragmentation. Changes in neuronal density and mossy fiber sprouting were evaluated by Nissl and Timm staining, respectively.  Results: Behavioral assessments indicated that kainate-treated rats presented spontaneous seizures. Moreover, their alternation percentage scores in the Y-Maze test were lower (P<0.001). Likewise, the passive avoidance test confirmed learning disability in Kainate-treated rats (P<0.001). HGF administration reduced the number of spontaneous seizures, alternation percentage score (P<0.001), and cognitive disturbances (P<0.001). The histopathological results also showed that a protected HGF administration contributed to the reduction of neuronal loss in the CA3 subregion of the hippocampus and inhibited the formation of aberrant Mossy Fiber Sprouting (MFS) (P<0.01). Furthermore, the ELISA data indicated a significant decrease in GFAP (P<0.01) and DNA fragmentation (P<0.05) following HGF administration. Conclusion: Our findings demonstrated the validity of HGF in protection against the progression of the kainate-induced TLE in rats. This measure improved learning, cognitive disturbances and inhibited apoptosis and astrogliosis.http://bcn.iums.ac.ir/article-1-1562-en.htmlhepatocyte growth factortemporal lobe epilepsyastrogliosisapoptosismemory impairment
spellingShingle Sobhan Haghani
Nida Jamali-Raeufy
Motahareh Zeinivand
Soraya Mehrabi
Leila Aryan
Javad Fahanik-Babaei
Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis
Basic and Clinical Neuroscience
hepatocyte growth factor
temporal lobe epilepsy
astrogliosis
apoptosis
memory impairment
title Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis
title_full Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis
title_fullStr Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis
title_full_unstemmed Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis
title_short Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis
title_sort hepatocyte growth factor attenuates the severity of status epilepticus in kainic acid induced model of temporal lobe epilepsy by targeting apoptosis and astrogliosis
topic hepatocyte growth factor
temporal lobe epilepsy
astrogliosis
apoptosis
memory impairment
url http://bcn.iums.ac.ir/article-1-1562-en.html
work_keys_str_mv AT sobhanhaghani hepatocytegrowthfactorattenuatestheseverityofstatusepilepticusinkainicacidinducedmodeloftemporallobeepilepsybytargetingapoptosisandastrogliosis
AT nidajamaliraeufy hepatocytegrowthfactorattenuatestheseverityofstatusepilepticusinkainicacidinducedmodeloftemporallobeepilepsybytargetingapoptosisandastrogliosis
AT motaharehzeinivand hepatocytegrowthfactorattenuatestheseverityofstatusepilepticusinkainicacidinducedmodeloftemporallobeepilepsybytargetingapoptosisandastrogliosis
AT sorayamehrabi hepatocytegrowthfactorattenuatestheseverityofstatusepilepticusinkainicacidinducedmodeloftemporallobeepilepsybytargetingapoptosisandastrogliosis
AT leilaaryan hepatocytegrowthfactorattenuatestheseverityofstatusepilepticusinkainicacidinducedmodeloftemporallobeepilepsybytargetingapoptosisandastrogliosis
AT javadfahanikbabaei hepatocytegrowthfactorattenuatestheseverityofstatusepilepticusinkainicacidinducedmodeloftemporallobeepilepsybytargetingapoptosisandastrogliosis